Phoenestra GmbH

Startup

Phoenestra is focusing on stem cell technology platforms and products derived from these platforms. The most advanced product candidates are extracellular vesicle (EV) preparations from stable MSC lines (branded as EVscale(TM)) , several of these therapeutic assets are in pre-clinical evaluation. We characterize the molecular profilles of these EV preps and link these to biological functionalities tested in vitro and in vivo. With our approach we overcome current limitations in manufacturing of these complex products and enable the targeting of large therapeutic indications in Regenerative Medicine.

website